Wing Keung Chan

2.6k total citations · 1 hit paper
31 papers, 1.8k citations indexed

About

Wing Keung Chan is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Wing Keung Chan has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 12 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Wing Keung Chan's work include Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (12 papers) and T-cell and B-cell Immunology (6 papers). Wing Keung Chan is often cited by papers focused on Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (12 papers) and T-cell and B-cell Immunology (6 papers). Wing Keung Chan collaborates with scholars based in United States, Hong Kong and China. Wing Keung Chan's co-authors include Gcf Chan, Daniel Sze, YL Lau, Hkw Law, Michael A. Caligiuri, Jianhua Yu, Jianying Zhang, Wing Leung, Aaron Victor and Martha Holladay and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Wing Keung Chan

29 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effects of β-glucan on human immune and cancer cells

2009 680 citations Gcf Chan, Wing Keung Chan et al. Journal of Hematology & Oncology profile →

Peers

Countries citing papers authored by Wing Keung Chan

Since Specialization

Citations

This map shows the geographic impact of Wing Keung Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wing Keung Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wing Keung Chan more than expected).

Fields of papers citing papers by Wing Keung Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wing Keung Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wing Keung Chan. The network helps show where Wing Keung Chan may publish in the future.

Co-authorship network of co-authors of Wing Keung Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Wing Keung Chan. A scholar is included among the top collaborators of Wing Keung Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wing Keung Chan. Wing Keung Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting the DNA damage response through TBL1X in mantle cell lymphoma 2025 ·Blood Advances ·(unknown), (unknown), (unknown), (unknown), (unknown), Liudmyla Tsyba, (unknown), (unknown), (unknown), (unknown), (unknown), Neeraj Jain, (unknown), Lalit Sehgal, Wing Keung Chan, Walter Hanel, Jack C. Yalowich, Robert A. Baiocchi, Lapo Alinari	1
2	Designs of NKG2D-based immunotherapeutics for cancer 2025 ·Frontiers in Immunology ·Jianfeng Han, Youwei Wang, Gcf Chan, Wing Keung Chan	4
3	Sepsis induced dysfunction of liver type 1 innate lymphoid cells 2024 ·BMC Immunology ·(unknown), (unknown), (unknown), Yumo Zhang, Wing Keung Chan, Yan Lu, Xiaohong Li, Zhouxin Yang, (unknown)	0
4	CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model 2024 ·Blood Advances ·(unknown), (unknown), (unknown), Yandi Gao, (unknown), (unknown), (unknown), (unknown), (unknown), Malith Karunasiri, (unknown), (unknown), Punam Malik, (unknown), Wing Keung Chan, Meisam Naeimi Kararoudi, Hannah Choe, Ramiro Garzon, Parvathi Ranganathan	3
5	A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models 2023 ·Experimental Hematology and Oncology ·Wing Keung Chan, Jessica Williams, (unknown), (unknown), (unknown), Zehua Bian, (unknown), (unknown), (unknown), Walter Hanel, (unknown), (unknown), Nathan Denlinger, Xiaoli Zhang, Natarajan Muthusamy, Sumithira Vasu, Marcos de Lima, Yiping Yang, Robert A. Baiocchi, Lapo Alinari	9
6	Role of IL-22 in intestinal microenvironment and potential targeted therapy through diet 2022 ·Immunologic Research ·(unknown), Wing Keung Chan, Jiming Wang, Zhouxin Yang, Youwei Wang	1
7	A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells 2022 ·Experimental Hematology and Oncology ·Walter Hanel, (unknown), Youssef Youssef, (unknown), Liudmyla Tsyba, (unknown), Bradley W. Blaser, Dennis Huszar, (unknown), Liwen Zhang, Morgan S. Schrock, Matthew K. Summers, Wing Keung Chan, (unknown), Bethany L. Mundy-Bosse, Selina Chen‐Kiang, Alexey V. Danilov, Kami J. Maddocks, Robert A. Baiocchi, Lapo Alinari	4
8	PRMT5 Inhibition Promotes FOXO1 Tumor Suppressor Activity to Drive a Pro-Apoptotic Program That Creates Vulnerability to Combination Treatment with Venetoclax in Mantle Cell Lymphoma 2021 ·Blood ·(unknown), Inah Hwang, (unknown), (unknown), (unknown), (unknown), Youssef Youssef, Wing Keung Chan, (unknown), (unknown), Yang Zhang, Kris Vaddi, Selina Chen‐Kiang, Maurizio Di Liberto, Olivier Elemento, Lalit Sehgal, Lapo Alinari, Peggy Scherle, Rosa Lapalombella, Jihye Paik, Robert A. Baiocchi	2
9	A CS1-NKG2D Bispecific Antibody Collectively Activates Cytolytic Immune Cells against Multiple Myeloma 2018 ·Cancer Immunology Research ·Wing Keung Chan, Siwen Kang, Youssef Youssef, (unknown), (unknown), Alex M. Carter, Elshafa H. Ahmed, Aman Prasad, Luxi Chen, Jianying Zhang, Don M. Benson, Michael A. Caligiuri, Jianhua Yu	98
10	The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma 2018 ·Cancer Immunology Immunotherapy ·Rosa Nguyen, Jim Houston, Wing Keung Chan, David Finkelstein, Michael A. Dyer	23
11	CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells 2015 ·Scientific Reports ·Jianfeng Han, Jianhong Chu, Wing Keung Chan, Jianying Zhang, Youwei Wang, Justus B. Cohen, Aaron Victor, Walter H. Meisen, Sung-Hak Kim, Paola Grandi, Qi‐En Wang, Xiaoming He, Ichiro Nakano, E. Antonio Chiocca, Joseph C. Glorioso, Balveen Kaur, Michael A. Caligiuri, Jianhua Yu	280
12	Genome-wide single-nucleotide polymorphism analysis revealed SUFU suppression of acute graft-versus-host disease through downregulation of HLA-DR expression in recipient dendritic cells 2015 ·Scientific Reports ·Rafijul Bari, Christine Hartford, Wing Keung Chan, Queenie Vong, (unknown), Kwan Gan, Yinmei Zhou, Cheng Cheng, Guolian Kang, Sheila Shurtleff, Victoria Turner, Ching‐Hon Pui, James R. Downing, Wing Leung	13
13	Ex Vivo Activation of CD56+ Immune Cells That Eradicate Neuroblastoma 2013 ·Cancer Research ·Piya Rujkijyanont, Wing Keung Chan, Paul W. Eldridge, Timothy Lockey, Martha Holladay, Barbara Rooney, Andrew M. Davidoff, Wing Leung, Queenie Vong	20
14	Antibody-Dependent Cell-Mediated Cytotoxicity Overcomes NK Cell Resistance in MLL -Rearranged Leukemia Expressing Inhibitory KIR Ligands but Not Activating Ligands 2012 ·Clinical Cancer Research ·Wing Keung Chan, May Kung Sutherland, Ying Li, Jonathan Zalevsky, (unknown), Wing Leung	31
15	Brazilian green propolis and its constituent, Artepillin C inhibits allogeneic activated human CD4 T cells expansion and activation 2011 ·Journal of Ethnopharmacology ·Ka‐Wai Cheung, Daniel Sze, Wing Keung Chan, Ruixia Deng, Wenwei Tu, Gcf Chan	45
16	The effects of β-glucan on human immune and cancer cells breakdown → 2009 ·Journal of Hematology & Oncology ·Gcf Chan, Wing Keung Chan, Daniel Sze	680
17	High-Throughput Screening Platform for Anticancer Therapeutic Drug Cytotoxicity 2008 ·Assay and Drug Development Technologies ·(unknown), Rebecca H. Roubin, Aaron C. Tan, Wing Keung Chan, Daniel Sze	24
18	MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-γ challenge 2008 ·Experimental Hematology ·Wing Keung Chan, Allan S. Y. Lau, J. Li, Hkw Law, YL Lau, Gcf Chan	95
19	Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors 2008 ·BMC Cell Biology ·(unknown), (unknown), Wing Keung Chan, Hkw Law, YL Lau, Gcf Chan	62
20	Ganoderma lucidum Mycelium and Spore Extracts as Natural Adjuvants for Immunotherapy 2005 ·The Journal of Alternative and Complementary Medicine ·Wing Keung Chan, (unknown), Hkw Law, Wing‐Tak Wong, Marcel W.L. Koo, Allan S. Lau, YL Lau, Gcf Chan	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact